Preclinical development of an ex vivo gene therapy for Mucopolysaccharidosis type II

被引：0
|
作者：
Das, S. [1 ]
Rruga, F. [2 ]
Rigon, L. [2 ]
Patel, J. [1 ]
Milazzo, R. [2 ]
Poletti, V. [1 ,2 ]
Biffi, A. [2 ]
机构：
[1] Harvard Med Sch, Boston Childrens Canc & Blood Disorders Ctr, Dana Farber, Boston, MA USA
[2] Univ Padua, Womans & Child Hlth, Dept Pediat, Hematol & Oncol Ctr, Padua, Italy
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 23-24期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR04
引用
收藏
页码：A3 / A3
页数：1
相关论文
共 50 条
  • [31] An innovative platform approach for the preclinical development of ex-vivo gene therapy for lysosomal storage disorders with skeletal
    Crippa, S.
    Scala, S.
    Alberti, G.
    Forni, C.
    Berti, M.
    Quaranta, P.
    Santi, L.
    De Ponti, G.
    Jofra-Hernandez, R.
    Basso-Ricci, L.
    Rilievo, A. A.
    Visigalli, I.
    Cecere, F.
    Zonari, E.
    Consiglieri, G.
    Tucci, F.
    Cossutta, M.
    Albertini, P.
    Parini, R.
    Gentner, B.
    Bernardo, M. E.
    Aiuti, A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A246 - A246
  • [32] Biochemical Engraftment and Clinical Outcomes Following Ex-Vivo Autologous Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA
    Wynn, Robert F.
    Kinsella, Jane L.
    Holley, Rebecca J.
    Potter, Jane
    Thrasher, Adrian J.
    Booth, Claire
    Buckland, Karen
    Izotova, Natalia
    Rust, Stewart
    Weisberg, Daniel
    Church, Heather J.
    Tylee, Karen L.
    Brammeier, Kathryn L.
    Lee, Helena
    Ford, Laura
    Sadegholnejat, Atusa
    Jones, Simon A.
    Ellison, Stuart
    Bigger, Brian
    BLOOD, 2022, 140 : 1897 - 1898
  • [33] In vivo preclinical studies for the development of a gene therapy for IPEX patient
    Mel, E. R.
    Passerini, L.
    Fousteri, G.
    Sartirana, C.
    Russo, F.
    Roncarolo, M.
    Bacchetta, R.
    IMMUNOLOGY, 2012, 137 : 688 - 688
  • [34] Development of an Ex Vivo Gene Therapy for Frontotemporal Dementia (FTD)
    Ciervo, Yuri
    Rigon, Laura
    Spadini, Silvia
    Accardo, Massimo
    Milazzo, Rita
    Biffi, Alessandra
    MOLECULAR THERAPY, 2022, 30 (04) : 125 - 125
  • [35] Development of an Ex Vivo Gene Therapy for Frontotemporal Dementia (FTD)
    Ciervo, Yuri
    Spadini, Silvia
    Accardo, Massimo
    Milazzo, Rita
    Biffi, Alessandra
    MOLECULAR THERAPY, 2023, 31 (04) : 134 - 135
  • [36] Development of an ex vivo Gene Therapy for Frontotemporal Dementia (FTD)
    Ciervo, Y.
    Rigon, L.
    Spadini, S.
    Accardo, M.
    Milazzo, R.
    Biffi, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A52 - A53
  • [37] A large preclinical animal model to assess ex vivo skin gene therapy applications
    Pfuetzner, Wolfgang
    Joari, Mohammed R.
    Foster, Ruth-Ann
    Vogel, Jonathan C.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 298 (01) : 16 - 22
  • [38] A large preclinical animal model to assess ex vivo skin gene therapy applications
    Wolfgang Pfützner
    Mohammed R. Joari
    Ruth-Ann Foster
    Jonathan C. Vogel
    Archives of Dermatological Research, 2006, 298 : 16 - 22
  • [39] Clinical outcomes and sustained biochemical engraftment following ex-vivo autologous stem cell gene therapy for mucopolysaccharidosis type IIIA
    Jones, Simon
    Kinsella, Jane
    Holley, Rebecca J.
    Potter, Jane
    Booth, Claire
    Buckland, Karen
    Rust, Stewart
    Bromley, Rebecca
    Church, Heather J.
    Lee, Helena
    Ford, Laura
    Learmonth, Yuko Ishikawa
    Searle, Rachel
    Ellison, Stuart M.
    Wynn, Robert
    Bigger, Brian
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [40] Development of alternative gene transfer techniques for ex vivo and in vivo gene therapy in a canine model
    Noda, Masashi
    Tatsumi, Kohei
    Matsui, Hideto
    Matsunari, Yasunori
    Sato, Takeshi
    Fukuoka, Yasushi
    Hotta, Akitsu
    Okano, Teruo
    Kichikawa, Kimihiko
    Sugimoto, Mitsuhiko
    Shima, Midori
    Nishio, Kenji
    REGENERATIVE THERAPY, 2021, 18 : 347 - 354
12345